Definium Therapeutics, Inc. · NASDAQ:DFTX

Wiley Matthew T. received 62,500 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Aug 12, 2026 · Filed Aug 12, 2026

On Aug 12, 2026, Wiley Matthew T. (Chief Commercial Officer) received 62,500 Definium Therapeutics, Inc. shares as an award, leaving 237,133 shares. Filed Aug 12, 2026 (Form 4).

Awarded
62,500 shares
Holding after
237,133 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 12, 2026Common SharesAward62,500237,133Direct

Source

View original at SEC

Related